Prothena (PRTA) News Today $12.14 +0.40 (+3.41%) Closing price 04/2/2025 04:00 PM EasternExtended Trading$11.89 -0.25 (-2.06%) As of 04/2/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Prothena (NASDAQ:PRTA) Reaches New 12-Month Low - Here's What HappenedProthena (NASDAQ:PRTA) Reaches New 12-Month Low - What's Next?April 2 at 10:56 AM | marketbeat.comProthena (NASDAQ:PRTA) Stock Price Down 7.2% - Time to Sell?Prothena (NASDAQ:PRTA) Shares Down 7.2% - What's Next?April 1 at 2:00 PM | marketbeat.comBrokers Issue Forecasts for Prothena FY2025 EarningsProthena Co. plc (NASDAQ:PRTA - Free Report) - Analysts at Chardan Capital issued their FY2025 EPS estimates for Prothena in a note issued to investors on Monday, March 24th. Chardan Capital analyst R. Li anticipates that the biotechnology company will post earnings per share of ($3.25) for the yMarch 28, 2025 | marketbeat.comAnalysts Offer Predictions for Prothena FY2025 EarningsMarch 28, 2025 | americanbankingnews.comProthena (NASDAQ:PRTA) Trading 4.8% Higher - Should You Buy?Prothena (NASDAQ:PRTA) Shares Up 4.8% - Here's WhyMarch 27, 2025 | marketbeat.comBank of New York Mellon Corp Has $2.08 Million Stake in Prothena Co. plc (NASDAQ:PRTA)Bank of New York Mellon Corp boosted its position in shares of Prothena Co. plc (NASDAQ:PRTA - Free Report) by 14.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 150,238 shares of the biotechnologMarch 22, 2025 | marketbeat.comProthena Co. plc (NASDAQ:PRTA) Shares Sold by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. cut its holdings in Prothena Co. plc (NASDAQ:PRTA - Free Report) by 25.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 91,840 shares of the biotechnology company'March 20, 2025 | marketbeat.comProthena Co. plc (NASDAQ:PRTA) Given Consensus Recommendation of "Moderate Buy" by AnalystsProthena Co. plc (NASDAQ:PRTA - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eight analysts that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendatioMarch 17, 2025 | marketbeat.comZacks Research Has Positive Outlook of Prothena Q1 EarningsProthena Co. plc (NASDAQ:PRTA - Free Report) - Equities researchers at Zacks Research upped their Q1 2025 EPS estimates for Prothena in a research note issued on Wednesday, March 12th. Zacks Research analyst E. Bagri now forecasts that the biotechnology company will earn ($1.06) per share for theMarch 17, 2025 | marketbeat.comZacks Research Estimates Prothena FY2027 EarningsProthena Co. plc (NASDAQ:PRTA - Free Report) - Zacks Research issued their FY2027 earnings estimates for Prothena in a report issued on Wednesday, March 12th. Zacks Research analyst E. Bagri anticipates that the biotechnology company will post earnings per share of ($3.04) for the year. The conseMarch 15, 2025 | marketbeat.comProthena (NASDAQ:PRTA) Trading Down 8.1% - Should You Sell?Prothena (NASDAQ:PRTA) Trading Down 8.1% - What's Next?March 12, 2025 | marketbeat.comFoundation Wealth Management LLC Makes New $270,000 Investment in Prothena Co. plc (NASDAQ:PRTA)Foundation Wealth Management LLC purchased a new stake in shares of Prothena Co. plc (NASDAQ:PRTA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 19,471 shares of the biotechnology company's stoMarch 8, 2025 | marketbeat.comProthena Corporation: Multiple Failures Make It RiskyMarch 3, 2025 | seekingalpha.comProthena (NASDAQ:PRTA) Shares Up 6.5% - Should You Buy?Prothena (NASDAQ:PRTA) Stock Price Up 6.5% - Time to Buy?March 1, 2025 | marketbeat.comProthena (NASDAQ:PRTA) Given New $110.00 Price Target at Piper SandlerPiper Sandler increased their price target on Prothena from $94.00 to $110.00 and gave the company an "overweight" rating in a report on Wednesday.February 27, 2025 | marketbeat.comProthena price target raised to $110 from $94 at Piper SandlerFebruary 26, 2025 | markets.businessinsider.comProthena (NASDAQ:PRTA) Upgraded at StockNews.comStockNews.com upgraded shares of Prothena from a "sell" rating to a "hold" rating in a research note on Monday.February 25, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for Prothena Q4 Earnings?Prothena Co. plc (NASDAQ:PRTA - Free Report) - Equities research analysts at HC Wainwright issued their Q4 2025 earnings per share estimates for shares of Prothena in a report released on Friday, February 21st. HC Wainwright analyst A. Fein anticipates that the biotechnology company will earn ($0February 24, 2025 | marketbeat.comProthena Reports 2024 Financial Results and 2025 OutlookFebruary 22, 2025 | tipranks.comProthena’s Balanced Earnings Call Highlights Growth and ChallengesFebruary 22, 2025 | tipranks.comRoyal Bank of Canada Cuts Prothena (NASDAQ:PRTA) Price Target to $20.00Royal Bank of Canada reduced their target price on Prothena from $24.00 to $20.00 and set a "sector perform" rating on the stock in a research note on Friday.February 22, 2025 | marketbeat.comProthena's (PRTA) "Overweight" Rating Reaffirmed at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating on shares of Prothena in a research report on Friday.February 22, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Prothena (NASDAQ:PRTA)HC Wainwright reissued a "buy" rating and issued a $48.00 price objective on shares of Prothena in a research note on Friday.February 22, 2025 | marketbeat.comProthena's (PRTA) "Buy" Rating Reaffirmed at Chardan CapitalChardan Capital reiterated a "buy" rating and set a $40.00 target price on shares of Prothena in a research note on Friday.February 22, 2025 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Prothena (PRTA), Integer Holdings (ITGR)February 22, 2025 | markets.businessinsider.comProthena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business HighlightsFebruary 21, 2025 | uk.finance.yahoo.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Insulet (PODD), Prothena (PRTA) and Travere Therapeutics (TVTX)February 21, 2025 | markets.businessinsider.comProthena price target lowered to $20 from $24 at RBC CapitalFebruary 21, 2025 | markets.businessinsider.comProthena Corporation plc (NASDAQ:PRTA) Q4 2024 Earnings Call TranscriptFebruary 21, 2025 | msn.comProthena (NASDAQ:PRTA) Issues Earnings Results, Misses Estimates By $0.06 EPSProthena (NASDAQ:PRTA - Get Free Report) released its quarterly earnings data on Thursday. The biotechnology company reported ($1.08) EPS for the quarter, missing the consensus estimate of ($1.02) by ($0.06). Prothena had a negative net margin of 98.86% and a negative return on equity of 24.19%.February 21, 2025 | marketbeat.comProthena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ...February 21, 2025 | gurufocus.comProthena outlines potential multi-billion dollar opportunity with birtamimab launch by 2026February 21, 2025 | msn.comJMP Securities Keeps Their Buy Rating on Prothena (PRTA)February 21, 2025 | markets.businessinsider.comQ4 2024 Prothena Corporation PLC Earnings Call TranscriptFebruary 21, 2025 | gurufocus.comProthena Corporation plc (PRTA) Q4 2024 Earnings Call TranscriptFebruary 20, 2025 | seekingalpha.comProthena Corporation plc 2024 Q4 - Results - Earnings Call PresentationFebruary 20, 2025 | seekingalpha.comProthena (NASDAQ:PRTA) Trading Up 6% - Here's WhyProthena (NASDAQ:PRTA) Stock Price Up 6% - Still a Buy?February 20, 2025 | marketbeat.comProthena Co. plc (NASDAQ:PRTA) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Prothena Co. plc (NASDAQ:PRTA - Get Free Report) have been assigned an average rating of "Moderate Buy" from the seven brokerages that are currently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and five have assigned a buyFebruary 20, 2025 | marketbeat.comKuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law FirmFebruary 17, 2025 | gurufocus.comKuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law FirmFebruary 17, 2025 | globenewswire.comProthena (PRTA) to Release Quarterly Earnings on ThursdayProthena (NASDAQ:PRTA) will be releasing earnings before the market opens on Thursday, February 20, Financial Modeling Prep reports.February 13, 2025 | marketbeat.comFocused Wealth Management Inc Buys Shares of 32,129 Prothena Co. plc (NASDAQ:PRTA)Focused Wealth Management Inc bought a new stake in shares of Prothena Co. plc (NASDAQ:PRTA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 32,129 shares of the biotechFebruary 9, 2025 | marketbeat.comProthena (NASDAQ:PRTA) Stock Price Expected to Rise, Oppenheimer Analyst SaysOppenheimer increased their price target on shares of Prothena from $58.00 to $62.00 and gave the company an "outperform" rating in a research report on Friday.February 7, 2025 | marketbeat.comProthena price target raised to $62 from $58 at OppenheimerFebruary 7, 2025 | markets.businessinsider.comFurther weakness as Prothena (NASDAQ:PRTA) drops 16% this week, taking three-year losses to 61%February 4, 2025 | finance.yahoo.comSG Americas Securities LLC Increases Holdings in Prothena Co. plc (NASDAQ:PRTA)SG Americas Securities LLC grew its holdings in Prothena Co. plc (NASDAQ:PRTA - Free Report) by 167.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 37,612 shares of the biotechnology company's stock after acquiring an additional 23,525 sFebruary 1, 2025 | marketbeat.comKuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law FirmJanuary 30, 2025 | markets.businessinsider.comProthena (NASDAQ:PRTA) Trading Down 4.8% - Should You Sell?Prothena (NASDAQ:PRTA) Stock Price Down 4.8% - Here's What HappenedJanuary 30, 2025 | marketbeat.comZacks Research Issues Positive Outlook for Prothena EarningsProthena Co. plc (NASDAQ:PRTA - Free Report) - Equities research analysts at Zacks Research raised their Q2 2025 earnings estimates for shares of Prothena in a research note issued on Monday, January 27th. Zacks Research analyst E. Bagri now forecasts that the biotechnology company will post earnJanuary 30, 2025 | marketbeat.comDuncan Williams Asset Management LLC Purchases 20,450 Shares of Prothena Co. plc (NASDAQ:PRTA)Duncan Williams Asset Management LLC lifted its position in shares of Prothena Co. plc (NASDAQ:PRTA - Free Report) by 41.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 69,199 shares of the biotechnologJanuary 26, 2025 | marketbeat.com Remove Ads Get Prothena News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTA and its competitors with MarketBeat's FREE daily newsletter. Email Address PRTA Media Mentions By Week PRTA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTA News Sentiment▼0.720.53▲Average Medical News Sentiment PRTA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTA Articles This Week▼83▲PRTA Articles Average Week Remove Ads Get Prothena News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HUTCHMED News Today Amneal Pharmaceuticals News Today ImmunityBio News Today Xenon Pharmaceuticals News Today MoonLake Immunotherapeutics News Today Biohaven News Today Bausch Health Companies News Today Twist Bioscience News Today NewAmsterdam Pharma News Today Vericel News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRTA) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prothena Co. plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Prothena With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRTA Stock Free PRTA Stock Alerts